Frequently Asked Questions

Yes. Brevicillin® is also suitable for children undergoing therapy with Amoxicillin or Amoxicillin/Clavulanic Acid.
In particular, Brevicillin® Drops have been specifically formulated to be “child-friendly” and can also be used in newborns.

• Brevicillin® Stickpack Orosolubili & Brevicillin® Capsule: contain the same probiotic content, equal to at least 20 billion live cells of Bifidobacterium breve PRL2020 per dose. They differ exclusively in the hiring method

• Stick packs: orosoluble powder sachets, to be taken directly in the mouth or dissolved in water
• Capsules: to be swallowed with water

Brevicillin® Drops: 10 ml bottle (150 drops in total), with 5 billion live cells per dose (5 drops). Oil-based formulation, ideal for younger children and also suitable for newborns.

Yes, the content of the Stick packs can be dissolved directly in the mouth without adding liquids.
Drops, on the other hand, should be taken directly into the oral cavity or diluted in cold or lukewarm drinks.

It is recommended to take one dose of the product, regardless of the format, after each antibiotic dose:

• Brevicillin® Orosoluble Stick packs: 1 stick after each antibiotic dose
• Brevicillin® Capsules: 1 capsule after each antibiotic dose
• Brevicillin® Drops: 5 drops after each antibiotic dose

No interactions with other medicines have been reported. Before starting any treatment, it is recommended to consult your doctor.

All products in the Brevicillin® line (Brevicillin® Stick packs, Brevicillin® Capsules and Brevicillin® Drops) have been developed to be taken in combination with Amoxicillin or Amoxicillin/Clavulanic Acid, antibiotics against which the strain Bifidobacterium breve PRL2020 shows specific intrinsic resistance.

No significant resistance of B. breve PRL2020 is known against other antibiotics. Nevertheless, Brevicillin® products may still represent a valid support for restoring intestinal microbiota balance. However, if treatments with antibiotics other than Amoxicillin or Amoxicillin/Clavulanic Acid are required, it is recommended to start taking the product from the last day of antibiotic therapy and not during concomitant use.

No side effects have been observed. In case of excessive or accidental intake, consult your doctor.

• Stick packs & Capsules: contain probiotic microorganisms sensitive to heat and must therefore be stored in the refrigerator (+2°C / +8°C).
• Drops: contain the same probiotic microorganisms but in an oil suspension and can be stored at room temperature, in a cool and dry place, away from heat sources. In this format, the oil acts as a natural “thermal insulator” and, based on internal stability studies, it has been shown to ensure the correct bacterial concentration until the end of the product shelf life even when stored at room temperature
•  

No, all products of the Brevicillin® line (Stick packs, Capsules and Drops) are gluten-free and are therefore also suitable for people with coeliac disease.

No, all products of the Brevicillin® line (Stick packs, Capsules and Drops) do not contain lactose or milk derivatives and are therefore also suitable for people with lactose intolerance.

No, products of the Brevicillin® line (Stick packs, Capsules and Drops) do not contain aspartame.

Yes, all products of the Brevicillin® line (Stick packs, Capsules and Drops) do not contain ingredients of animal origin and are therefore suitable for vegetarians and vegans.